Fabris C, Pirisi M, Panozzo M P, Soardo G, Toniutto P, Hocza V, Bartoli E
Cattedra di Medicina Interna, Università degli Studi, Udine, Italy.
J Clin Pathol. 1993 Apr;46(4):364-7. doi: 10.1136/jcp.46.4.364.
To investigate variations in serum lipid peroxide activities in relation to various clinical entities of liver disease.
Serum lipid peroxides were measured fluorometrically in eight patients with acute hepatitis, six with liver steatofibrosis, five with chronic persistent hepatitis, 15 with chronic active hepatitis, 28 with liver cirrhosis, 22 with hepatocellular carcinoma; 19 patients with extrahepatic disease (six malignant, 13 benign) were used as controls.
Higher serum lipid peroxide concentrations were found in patients with acute hepatitis (4.52 (SEM 0.56)) nmol/ml than in all other groups of patients (p < 0.01). No significant difference was found among the mean values detected in the groups of patients affected by chronic liver disease and extrahepatic diseases. A history of chronic alcohol consumption was not associated with higher lipid peroxide concentrations. A significant correlation (R2 = 0.4538, R = 0.6737, F = 7.617, p = 0.0000) was found between serum lipid peroxides and a set of indices of inflammation (ESR, total leucocyte count, C-reactive protein) and of hepatic function (aspartate aminotransferase (AST) or alkaline phosphatase (ALP) or bilirubin). Of these, bilirubin was the most significant indicator of inflammation. Analysis of covariance showed a significant difference in lipid peroxide values among groups, even when bilirubin was chosen as an independent variable.
Raised serum lipid peroxide concentrations can be found during acute inflammatory liver disease. Acute change in liver function, reflected by high bilirubin concentrations, seems to be more important for intravascular liberation of lipid peroxides than existence of specific aetiological factors or of severe longstanding global liver damage.
研究血清脂质过氧化物活性与各种肝病临床类型之间的关系。
采用荧光法测定了8例急性肝炎患者、6例肝脂肪纤维化患者、5例慢性持续性肝炎患者、15例慢性活动性肝炎患者、28例肝硬化患者、22例肝细胞癌患者的血清脂质过氧化物水平;选取19例肝外疾病患者(6例恶性疾病,13例良性疾病)作为对照。
急性肝炎患者的血清脂质过氧化物浓度(4.52(标准误0.56))nmol/ml高于所有其他患者组(p<0.01)。在慢性肝病患者组和肝外疾病患者组中检测到的平均值之间未发现显著差异。长期慢性饮酒史与较高的脂质过氧化物浓度无关。血清脂质过氧化物与一组炎症指标(血沉、白细胞总数、C反应蛋白)和肝功能指标(天冬氨酸转氨酶(AST)或碱性磷酸酶(ALP)或胆红素)之间存在显著相关性(R2 = 0.4538,R = 0.6737,F = 7.617,p = 0.0000)。其中,胆红素是炎症的最显著指标。协方差分析显示,即使将胆红素作为自变量,各组之间的脂质过氧化物值仍存在显著差异。
在急性炎症性肝病期间可发现血清脂质过氧化物浓度升高。高胆红素浓度所反映的肝功能急性变化,似乎比特定病因因素或严重的长期整体肝损伤的存在对脂质过氧化物的血管内释放更为重要。